M. Reck
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 4
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Peter Ellis (1 shared paper)M. Pérol (1 shared paper)Rodryg Ramlau (2 shared papers)G. Robinet (1 shared paper)Malcolm Ranson (1 shared paper)Tobias Welte (1 shared paper)Kenneth J. O’Byrne (1 shared paper)A. Szczęsna (1 shared paper)
- Journals
- Journal of Thoracic Oncology (6 papers)Journal of Clinical Oncology (4 papers)Annals of Oncology (4 papers)Critical Reviews in Oncology/Hematology (1 paper)Pneumologie (2 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
M. Reck
20 papers receiving 315 citations
Peers
Comparison fields: 5 of 26
- Oncology 212
- Pulmonary and Respiratory Medicine 180
- Immunology 29
- Hepatology 8
- Epidemiology 32
Countries citing papers authored by M. Reck
This map shows the geographic impact of M. Reck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Reck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Reck more than expected).
Fields of papers citing papers by M. Reck
This network shows the impact of papers produced by M. Reck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Reck. The network helps show where M. Reck may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Reck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 216 | |
| 2 | 2019 | 50 | |
| 3 | 2011 | 19 | |
| 4 | 2017 | 6 | |
| 5 | 2018 | 5 | |
| 6 | 2021 | 5 | |
| 7 | 2011 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2009 | 3 | |
| 10 | 2011 | 2 | |
| 11 | 2021 | 2 | |
| 12 | 2024 | 2 | |
| 13 | Rash as a marker for the efficacy of necitumumab in the SQUIRE Study | 2015 | 2 |
| 14 | 進行性NSCLC患者におけるカルボプラチンとパクリタキセルを併用した,TRAIL-R1アゴニスト単クローン抗体マパツムマブの無作為化第2相試験 | 2010 | 1 |
| 15 | 2009 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2008 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2006 | 1 | |
| 20 | 2012 | 1 |
About M. Reck
M. Reck is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Molecular Biology, having authored 20 papers that have together received 326 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (212 citations), Pulmonary and Respiratory Medicine (180 citations), Immunology (29 citations), Hepatology (8 citations) and Epidemiology (32 citations). M. Reck has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Peter Ellis, M. Pérol, Rodryg Ramlau, G. Robinet, Malcolm Ranson, Tobias Welte, Kenneth J. O’Byrne, A. Szczęsna, Manuel Constenla and Rafael Rosell. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Annals of Oncology, Critical Reviews in Oncology/Hematology and Pneumologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.